+1-626-295-2442 (Worldwide) 400-606-8865 (China)
Sign in Register
English
United States Measles Vaccine Market Report 2018

United States Measles Vaccine Market Report 2018


  • Publish date: 2018-01-25  | 
  • Pages: 105  | 
  • Tables: 123  | 
  • Hits: 27

  • Report Id: 27903  | 
  • Report Category: Measles Vaccine
  • Publish date: 2018-01-25  | 
  • Pages: 105
  • Tables: 123  | 
  • Hits: 27
In this report, the United States Measles Vaccine market is valued at USD XX million in 2017 and is expected to reach USD XX million by the end of 2025, growing at a CAGR of XX% between 2017 and 2025.

Geographically, this report splits the United States market into seven regions:

    The West

    Southwest

    The Middle Atlantic

    New England

    The South

    The Midwest

with sales (volume), revenue (value), market share and growth rate of Measles Vaccine in these regions, from 2013 to 2025 (forecast).

United States Measles Vaccine market competition by top manufacturers/players, with Measles Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

    GSK

    Sanofi-Pasteur

    Merck

    Novartis

    Pfizer

    Serum Institute of India

    China National Biotech Group

    Bavarian Nordic

    Emergent Biosolutions

    Medimmune

    Johnson & Johnson

    CSL Limited

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

    Mumps Measles Rubella Vaccine, Live (MMR-II)

    Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

    Children

    Adults

If you have any special requirements, please let us know and we will offer you the report as you want.

null
READ MORE
Table of Contents

United States Measles Vaccine Market Report 2018

1 Measles Vaccine Overview

    1.1 Product Overview and Scope of Measles Vaccine

    1.2 Classification of Measles Vaccine by Product Category

        1.2.1 United States Measles Vaccine Market Size (Sales Volume) Comparison by Type (2013-2025)

        1.2.2 United States Measles Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2017

        1.2.3 Mumps Measles Rubella Vaccine, Live (MMR-II)

        1.2.4 Mumps Measles Rubella and Varicella Virus Vaccine (Proquad)

    1.3 United States Measles Vaccine Market by Application/End Users

        1.3.1 United States Measles Vaccine Market Size (Consumption) and Market Share Comparison by Application (2013-2025)

        1.3.2 Children

        1.3.3 Adults

    1.4 United States Measles Vaccine Market by Region

        1.4.1 United States Measles Vaccine Market Size (Value) Comparison by Region (2013-2025)

        1.4.2 The West Measles Vaccine Status and Prospect (2013-2025)

        1.4.3 Southwest Measles Vaccine Status and Prospect (2013-2025)

        1.4.4 The Middle Atlantic Measles Vaccine Status and Prospect (2013-2025)

        1.4.5 New England Measles Vaccine Status and Prospect (2013-2025)

        1.4.6 The South Measles Vaccine Status and Prospect (2013-2025)

        1.4.7 The Midwest Measles Vaccine Status and Prospect (2013-2025)

    1.5 United States Market Size (Value and Volume) of Measles Vaccine (2013-2025)

        1.5.1 United States Measles Vaccine Sales and Growth Rate (2013-2025)

        1.5.2 United States Measles Vaccine Revenue and Growth Rate (2013-2025)

2 United States Measles Vaccine Market Competition by Players/Suppliers

    2.1 United States Measles Vaccine Sales and Market Share of Key Players/Suppliers (2013-2018)

    2.2 United States Measles Vaccine Revenue and Share by Players/Suppliers (2013-2018)

    2.3 United States Measles Vaccine Average Price by Players/Suppliers (2013-2018)

    2.4 United States Measles Vaccine Market Competitive Situation and Trends

        2.4.1 United States Measles Vaccine Market Concentration Rate

        2.4.2 United States Measles Vaccine Market Share of Top 3 and Top 5 Players/Suppliers

        2.4.3 Mergers & Acquisitions, Expansion in United States Market

    2.5 United States Players/Suppliers Measles Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 United States Measles Vaccine Sales (Volume) and Revenue (Value) by Region (2013-2018)

    3.1 United States Measles Vaccine Sales and Market Share by Region (2013-2018)

    3.2 United States Measles Vaccine Revenue and Market Share by Region (2013-2018)

    3.3 United States Measles Vaccine Price by Region (2013-2018)

4 United States Measles Vaccine Sales (Volume) and Revenue (Value) by Type (Product Category) (2013-2018)

    4.1 United States Measles Vaccine Sales and Market Share by Type (Product Category) (2013-2018)

    4.2 United States Measles Vaccine Revenue and Market Share by Type (2013-2018)

    4.3 United States Measles Vaccine Price by Type (2013-2018)

    4.4 United States Measles Vaccine Sales Growth Rate by Type (2013-2018)

5 United States Measles Vaccine Sales (Volume) by Application (2013-2018)

    5.1 United States Measles Vaccine Sales and Market Share by Application (2013-2018)

    5.2 United States Measles Vaccine Sales Growth Rate by Application (2013-2018)

    5.3 Market Drivers and Opportunities

6 United States Measles Vaccine Players/Suppliers Profiles and Sales Data

    6.1 GSK

        6.1.1 Company Basic Information, Manufacturing Base and Competitors

        6.1.2 Measles Vaccine Product Category, Application and Specification

            6.1.2.1 Product A

            6.1.2.2 Product B

        6.1.3 GSK Measles Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)

        6.1.4 Main Business/Business Overview

    6.2 Sanofi-Pasteur

        6.2.2 Measles Vaccine Product Category, Application and Specification

            6.2.2.1 Product A

            6.2.2.2 Product B

        6.2.3 Sanofi-Pasteur Measles Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)

        6.2.4 Main Business/Business Overview

    6.3 Merck

        6.3.2 Measles Vaccine Product Category, Application and Specification

            6.3.2.1 Product A

            6.3.2.2 Product B

        6.3.3 Merck Measles Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)

        6.3.4 Main Business/Business Overview

    6.4 Novartis

        6.4.2 Measles Vaccine Product Category, Application and Specification

            6.4.2.1 Product A

            6.4.2.2 Product B

        6.4.3 Novartis Measles Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)

        6.4.4 Main Business/Business Overview

    6.5 Pfizer

        6.5.2 Measles Vaccine Product Category, Application and Specification

            6.5.2.1 Product A

            6.5.2.2 Product B

        6.5.3 Pfizer Measles Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)

        6.5.4 Main Business/Business Overview

    6.6 Serum Institute of India

        6.6.2 Measles Vaccine Product Category, Application and Specification

            6.6.2.1 Product A

            6.6.2.2 Product B

        6.6.3 Serum Institute of India Measles Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)

        6.6.4 Main Business/Business Overview

    6.7 China National Biotech Group

        6.7.2 Measles Vaccine Product Category, Application and Specification

            6.7.2.1 Product A

            6.7.2.2 Product B

        6.7.3 China National Biotech Group Measles Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)

        6.7.4 Main Business/Business Overview

    6.8 Bavarian Nordic

        6.8.2 Measles Vaccine Product Category, Application and Specification

            6.8.2.1 Product A

            6.8.2.2 Product B

        6.8.3 Bavarian Nordic Measles Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)

        6.8.4 Main Business/Business Overview

    6.9 Emergent Biosolutions

        6.9.2 Measles Vaccine Product Category, Application and Specification

            6.9.2.1 Product A

            6.9.2.2 Product B

        6.9.3 Emergent Biosolutions Measles Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)

        6.9.4 Main Business/Business Overview

    6.10 Medimmune

        6.10.2 Measles Vaccine Product Category, Application and Specification

            6.10.2.1 Product A

            6.10.2.2 Product B

        6.10.3 Medimmune Measles Vaccine Sales, Revenue, Price and Gross Margin (2013-2018)

        6.10.4 Main Business/Business Overview

    6.11 Johnson & Johnson

    6.12 CSL Limited

7 Measles Vaccine Manufacturing Cost Analysis

    7.1 Measles Vaccine Key Raw Materials Analysis

        7.1.1 Key Raw Materials

        7.1.2 Price Trend of Key Raw Materials

        7.1.3 Key Suppliers of Raw Materials

        7.1.4 Market Concentration Rate of Raw Materials

    7.2 Proportion of Manufacturing Cost Structure

        7.2.1 Raw Materials

        7.2.2 Labor Cost

        7.2.3 Manufacturing Expenses

    7.3 Manufacturing Process Analysis of Measles Vaccine

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

    8.1 Measles Vaccine Industrial Chain Analysis

    8.2 Upstream Raw Materials Sourcing

    8.3 Raw Materials Sources of Measles Vaccine Major Manufacturers in 2017

    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

    9.1 Marketing Channel

        9.1.1 Direct Marketing

        9.1.2 Indirect Marketing

        9.1.3 Marketing Channel Development Trend

    9.2 Market Positioning

        9.2.1 Pricing Strategy

        9.2.2 Brand Strategy

        9.2.3 Target Client

    9.3 Distributors/Traders List

10 Market Effect Factors Analysis

    10.1 Technology Progress/Risk

        10.1.1 Substitutes Threat

        10.1.2 Technology Progress in Related Industry

    10.2 Consumer Needs/Customer Preference Change

    10.3 Economic/Political Environmental Change

11 United States Measles Vaccine Market Size (Value and Volume) Forecast (2018-2025)

    11.1 United States Measles Vaccine Sales Volume, Revenue Forecast (2018-2025)

    11.2 United States Measles Vaccine Sales Volume Forecast by Type (2018-2025)

    11.3 United States Measles Vaccine Sales Volume Forecast by Application (2018-2025)

    11.4 United States Measles Vaccine Sales Volume Forecast by Region (2018-2025)

12 Research Findings and Conclusion

13 Appendix

    13.1 Methodology/Research Approach

        13.1.1 Research Programs/Design

        13.1.2 Market Size Estimation

        13.1.3 Market Breakdown and Data Triangulation

    13.2 Data Source

        13.2.1 Secondary Sources

        13.2.2 Primary Sources

    13.3 Disclaimer

List of Tables and Figures

    Figure Product Picture of Measles Vaccine

    Figure United States Measles Vaccine Market Size (K Pcs) by Type (2013-2025)

    Figure United States Measles Vaccine Sales Volume Market Share by Type (Product Category) in 2017

    Figure Mumps Measles Rubella Vaccine, Live (MMR-II) Product Picture

    Figure Mumps Measles Rubella and Varicella Virus Vaccine (Proquad) Product Picture

    Figure United States Measles Vaccine Market Size (K Pcs) by Application (2013-2025)

    Figure United States Sales Market Share of Measles Vaccine by Application in 2017

    Figure Children Examples

    Table Key Downstream Customer in Children

    Figure Adults Examples

    Table Key Downstream Customer in Adults

    Figure United States Measles Vaccine Market Size (Million USD) by Region (2013-2025)

    Figure The West Measles Vaccine Revenue (Million USD) and Growth Rate (2013-2025)

    Figure Southwest Measles Vaccine Revenue (Million USD) and Growth Rate (2013-2025)

    Figure The Middle Atlantic Measles Vaccine Revenue (Million USD) and Growth Rate (2013-2025)

    Figure New England Measles Vaccine Revenue (Million USD) and Growth Rate (2013-2025)

    Figure The South of US Measles Vaccine Revenue (Million USD) and Growth Rate (2013-2025)

    Figure The Midwest Measles Vaccine Revenue (Million USD) and Growth Rate (2013-2025)

    Figure United States Measles Vaccine Sales (K Pcs) and Growth Rate (2013-2025)

    Figure United States Measles Vaccine Revenue (Million USD) and Growth Rate (2013-2025)

    Figure United States Measles Vaccine Market Major Players Product Sales Volume (K Pcs) (2013-2018)

    Table United States Measles Vaccine Sales (K Pcs) of Key Players/Suppliers (2013-2018)

    Table United States Measles Vaccine Sales Share by Players/Suppliers (2013-2018)

    Figure 2017 United States Measles Vaccine Sales Share by Players/Suppliers

    Figure 2017 United States Measles Vaccine Sales Share by Players/Suppliers

    Figure United States Measles Vaccine Market Major Players Product Revenue (Million USD) (2013-2018)

    Table United States Measles Vaccine Revenue (Million USD) by Players/Suppliers (2013-2018)

    Table United States Measles Vaccine Revenue Share by Players/Suppliers (2013-2018)

    Figure 2017 United States Measles Vaccine Revenue Share by Players/Suppliers

    Figure 2017 United States Measles Vaccine Revenue Share by Players/Suppliers

    Table United States Market Measles Vaccine Average Price (USD/Pcs) of Key Players/Suppliers (2013-2018)

    Figure United States Market Measles Vaccine Average Price (USD/Pcs) of Key Players/Suppliers in 2017

    Figure United States Measles Vaccine Market Share of Top 3 Players/Suppliers

    Figure United States Measles Vaccine Market Share of Top 5 Players/Suppliers

    Table United States Players/Suppliers Measles Vaccine Manufacturing Base Distribution and Sales Area

    Table United States Players/Suppliers Measles Vaccine Product Category

    Table United States Measles Vaccine Sales (K Pcs) by Region (2013-2018)

    Table United States Measles Vaccine Sales Share by Region (2013-2018)

    Figure United States Measles Vaccine Sales Share by Region (2013-2018)

    Figure United States Measles Vaccine Sales Market Share by Region in 2017

    Table United States Measles Vaccine Revenue (Million USD) and Market Share by Region (2013-2018)

    Table United States Measles Vaccine Revenue Share by Region (2013-2018)

    Figure United States Measles Vaccine Revenue Market Share by Region (2013-2018)

    Figure United States Measles Vaccine Revenue Market Share by Region in 2017

    Table United States Measles Vaccine Price (USD/Pcs) by Region (2013-2018)

    Table United States Measles Vaccine Sales (K Pcs) by Type (2013-2018)

    Table United States Measles Vaccine Sales Share by Type (2013-2018)

    Figure United States Measles Vaccine Sales Share by Type (2013-2018)

    Figure United States Measles Vaccine Sales Market Share by Type in 2017

    Table United States Measles Vaccine Revenue (Million USD) and Market Share by Type (2013-2018)

    Table United States Measles Vaccine Revenue Share by Type (2013-2018)

    Figure Revenue Market Share of Measles Vaccine by Type (2013-2018)

    Figure Revenue Market Share of Measles Vaccine by Type in 2017

    Table United States Measles Vaccine Price (USD/Pcs) by Types (2013-2018)

    Figure United States Measles Vaccine Sales Growth Rate by Type (2013-2018)

    Table United States Measles Vaccine Sales (K Pcs) by Application (2013-2018)

    Table United States Measles Vaccine Sales Market Share by Application (2013-2018)

    Figure United States Measles Vaccine Sales Market Share by Application (2013-2018)

    Figure United States Measles Vaccine Sales Market Share by Application in 2017

    Table United States Measles Vaccine Sales Growth Rate by Application (2013-2018)

    Figure United States Measles Vaccine Sales Growth Rate by Application (2013-2018)

    Table GSK Basic Information List

    Table GSK Measles Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

    Figure GSK Measles Vaccine Sales Growth Rate (2013-2018)

    Figure GSK Measles Vaccine Sales Market Share in United States (2013-2018)

    Figure GSK Measles Vaccine Revenue Market Share in United States (2013-2018)

    Table Sanofi-Pasteur Basic Information List

    Table Sanofi-Pasteur Measles Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

    Figure Sanofi-Pasteur Measles Vaccine Sales Growth Rate (2013-2018)

    Figure Sanofi-Pasteur Measles Vaccine Sales Market Share in United States (2013-2018)

    Figure Sanofi-Pasteur Measles Vaccine Revenue Market Share in United States (2013-2018)

    Table Merck Basic Information List

    Table Merck Measles Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

    Figure Merck Measles Vaccine Sales Growth Rate (2013-2018)

    Figure Merck Measles Vaccine Sales Market Share in United States (2013-2018)

    Figure Merck Measles Vaccine Revenue Market Share in United States (2013-2018)

    Table Novartis Basic Information List

    Table Novartis Measles Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

    Figure Novartis Measles Vaccine Sales Growth Rate (2013-2018)

    Figure Novartis Measles Vaccine Sales Market Share in United States (2013-2018)

    Figure Novartis Measles Vaccine Revenue Market Share in United States (2013-2018)

    Table Pfizer Basic Information List

    Table Pfizer Measles Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

    Figure Pfizer Measles Vaccine Sales Growth Rate (2013-2018)

    Figure Pfizer Measles Vaccine Sales Market Share in United States (2013-2018)

    Figure Pfizer Measles Vaccine Revenue Market Share in United States (2013-2018)

    Table Serum Institute of India Basic Information List

    Table Serum Institute of India Measles Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

    Figure Serum Institute of India Measles Vaccine Sales Growth Rate (2013-2018)

    Figure Serum Institute of India Measles Vaccine Sales Market Share in United States (2013-2018)

    Figure Serum Institute of India Measles Vaccine Revenue Market Share in United States (2013-2018)

    Table China National Biotech Group Basic Information List

    Table China National Biotech Group Measles Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

    Figure China National Biotech Group Measles Vaccine Sales Growth Rate (2013-2018)

    Figure China National Biotech Group Measles Vaccine Sales Market Share in United States (2013-2018)

    Figure China National Biotech Group Measles Vaccine Revenue Market Share in United States (2013-2018)

    Table Bavarian Nordic Basic Information List

    Table Bavarian Nordic Measles Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

    Figure Bavarian Nordic Measles Vaccine Sales Growth Rate (2013-2018)

    Figure Bavarian Nordic Measles Vaccine Sales Market Share in United States (2013-2018)

    Figure Bavarian Nordic Measles Vaccine Revenue Market Share in United States (2013-2018)

    Table Emergent Biosolutions Basic Information List

    Table Emergent Biosolutions Measles Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

    Figure Emergent Biosolutions Measles Vaccine Sales Growth Rate (2013-2018)

    Figure Emergent Biosolutions Measles Vaccine Sales Market Share in United States (2013-2018)

    Figure Emergent Biosolutions Measles Vaccine Revenue Market Share in United States (2013-2018)

    Table Medimmune Basic Information List

    Table Medimmune Measles Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2013-2018)

    Figure Medimmune Measles Vaccine Sales Growth Rate (2013-2018)

    Figure Medimmune Measles Vaccine Sales Market Share in United States (2013-2018)

    Figure Medimmune Measles Vaccine Revenue Market Share in United States (2013-2018)

    Table Johnson & Johnson Basic Information List

    Table CSL Limited Basic Information List

    Table Production Base and Market Concentration Rate of Raw Material

    Figure Price Trend of Key Raw Materials

    Table Key Suppliers of Raw Materials

    Figure Manufacturing Cost Structure of Measles Vaccine

    Figure Manufacturing Process Analysis of Measles Vaccine

    Figure Measles Vaccine Industrial Chain Analysis

    Table Raw Materials Sources of Measles Vaccine Major Players/Suppliers in 2017

    Table Major Buyers of Measles Vaccine

    Table Distributors/Traders List

    Figure United States Measles Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2018-2025)

    Figure United States Measles Vaccine Revenue (Million USD) and Growth Rate Forecast (2018-2025)

    Figure United States Measles Vaccine Price (USD/Pcs) Trend Forecast (2018-2025)

    Table United States Measles Vaccine Sales Volume (K Pcs) Forecast by Type (2018-2025)

    Figure United States Measles Vaccine Sales Volume (K Pcs) Forecast by Type (2018-2025)

    Figure United States Measles Vaccine Sales Volume (K Pcs) Forecast by Type in 2025

    Table United States Measles Vaccine Sales Volume (K Pcs) Forecast by Application (2018-2025)

    Figure United States Measles Vaccine Sales Volume (K Pcs) Forecast by Application (2018-2025)

    Figure United States Measles Vaccine Sales Volume (K Pcs) Forecast by Application in 2025

    Table United States Measles Vaccine Sales Volume (K Pcs) Forecast by Region (2018-2025)

    Table United States Measles Vaccine Sales Volume Share Forecast by Region (2018-2025)

    Figure United States Measles Vaccine Sales Volume Share Forecast by Region (2018-2025)

    Figure United States Measles Vaccine Sales Volume Share Forecast by Region in 2025

    Table Research Programs/Design for This Report

    Figure Bottom-up and Top-down Approaches for This Report

    Figure Data Triangulation

    Table Key Data Information from Secondary Sources

    Table Key Data Information from Primary Sources

null
We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
CONTACT US
We will be happy to help you find what you're looking for. Please call or email us
  • USA Office: +1-6262952442(International) ; +1-6265407211
  • Canada Office: +1-6133665094
Our clients
<
4321
>
>